The invention discloses a polypeptide or a pharmaceutically acceptable salt thereof. The polypeptide has an
amino acid sequence as shown in SEQ ID NO: 1 or an
amino acid sequence in a conservative modification form thereof. The polypeptide or the pharmaceutically acceptable salt thereof disclosed by the invention can be combined with GLP1R and is used for effectively activating the GLP1R. The GLP1R activating polypeptide is obtained through precise calculation and
deep learning model optimization, has a short sequence, has unique
amino acid arrangement compared with a traditional GLP-1 analogue, can effectively activate a GLP1R
receptor, can also be used for treating or preventing
metabolic disorder related diseases, and has a good application prospect. For example,
obesity, diabetes,
dyslipidemia related diseases,
fatty liver diseases, metabolic syndromes, non-
alcoholic fatty liver diseases and the like.